Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake

ACS Nano

Volumn 9, Issue 11, 2015, Pages 10758-10768

  Inturi, Swetha ^a   Wang, Guankui ^a   Chen, Fangfang ^b   Banda, Nirmal K ^c   Holers, V Michael ^c   Wu, LinPing ^d   Moghimi, Seyed Moein ^d   Simberg, Dmitri ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

alternative pathway; complement; immunity; iron oxide; leukocyte; leukocytes; nanoworms

Indexed keywords

BLOOD; BODY FLUIDS; COATINGS; DIAGNOSIS; DRUG PRODUCTS; IRON; LYMPHOCYTES; MAMMALS; NANOPARTICLES; PLATELETS; SUPERPARAMAGNETISM;

ALTERNATIVE PATHWAY; COMPLEMENT; IMMUNITY; LEUKOCYTE; LEUKOCYTES; NANOWORMS;

IRON OXIDES;

COMPLEMENT COMPONENT C3; CROSS LINKING REAGENT; DEXTRAN; HYDROGEL; MAGNETITE NANOPARTICLE; NANOPARTICLE; OPSONIN; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; COMPLEMENT ACTIVATION; ENDOCYTOSIS; HUMAN; HYDROGEL; LEUKOCYTE; METABOLISM; SURFACE PROPERTY; THROMBOCYTE; TISSUE DISTRIBUTION;

ANIMALS; BLOOD PLATELETS; COMPLEMENT ACTIVATION; COMPLEMENT C3; CROSS-LINKING REAGENTS; DEXTRANS; ENDOCYTOSIS; HUMANS; HYDROGEL; LEUKOCYTES; MAGNETITE NANOPARTICLES; MICE, INBRED BALB C; MICE, INBRED C57BL; NANOPARTICLES; OPSONIN PROTEINS; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84948402126     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.5b05061     Document Type: Article

References (67)

1. Grodzinski, P.; Farrell, D. Future Opportunities in Cancer Nanotechnology - Nci Strategic Workshop Report Cancer Res. 2014, 74, 1307-1310 10.1158/0008-5472.CAN-13-2787
2. Hull, L. C.; Farrell, D.; Grodzinski, P. Highlights of Recent Developments and Trends in Cancer Nanotechnology Research - View from NCI Alliance for Nanotechnology in Cancer Biotechnol. Adv. 2014, 32, 666-678 10.1016/j.biotechadv.2013.08.003
3. Taylor, P. R.; Martinez-Pomares, L.; Stacey, M.; Lin, H. H.; Brown, G. D.; Gordon, S. Macrophage Receptors and Immune Recognition Annu. Rev. Immunol. 2005, 23, 901-944 10.1146/annurev.immunol.23.021704.115816
4. Ricklin, D.; Hajishengallis, G.; Yang, K.; Lambris, J. D. Complement: A Key System for Immune Surveillance and Homeostasis Nat. Immunol. 2010, 11, 785-797 10.1038/ni.1923
5. Helmy, K. Y.; Katschke, K. J., Jr.; Gorgani, N. N.; Kljavin, N. M.; Elliott, J. M.; Diehl, L.; Scales, S. J.; Ghilardi, N.; van Lookeren Campagne, M. Crig: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens Cell 2006, 124, 915-927 10.1016/j.cell.2005.12.039
6. Peng, Q.; Li, K.; Sacks, S. H.; Zhou, W. The Role of Anaphylatoxins C3a and C5a in Regulating Innate and Adaptive Immune Responses Inflammation Allergy: Drug Targets 2009, 8, 236-246 10.2174/187152809788681038
7. Moghimi, S. M.; Farhangrazi, Z. S. Nanomedicine and the Complement Paradigm Nanomedicine 2013, 9, 458-460 10.1016/j.nano.2013.02.011
8. Andersen, A. J.; Hashemi, S. H.; Andresen, T. L.; Hunter, A. C.; Moghimi, S. M. Complement: Alive and Kicking Nanomedicines J. Biomed. Nanotechnol. 2009, 5, 364-372 10.1166/jbn.2009.1045
9. Andersen, A. J.; Robinson, J. T.; Dai, H.; Hunter, A. C.; Andresen, T. L.; Moghimi, S. M. Single-Walled Carbon Nanotube Surface Control of Complement Recognition and Activation ACS Nano 2013, 7, 1108-1119 10.1021/nn3055175
10. Wang, X.; Ishida, T.; Kiwada, H. Anti-Peg IgM Elicited by Injection of Liposomes is Involved in the Enhanced Blood Clearance of a Subsequent Dose of Pegylated Liposomes J. Controlled Release 2007, 119, 236-244 10.1016/j.jconrel.2007.02.010
11. Auguste, D. T.; Prud'homme, R. K.; Ahl, P. L.; Meers, P.; Kohn, J. Association of Hydrophobically-Modified Poly(Ethylene Glycol) with Fusogenic Liposomes Biochim. Biophys. Acta, Biomembr. 2003, 1616, 184-195 10.1016/j.bbamem.2003.08.007
12. Hamad, I.; Hunter, A. C.; Moghimi, S. M. Complement Monitoring of Pluronic 127 Gel and Micelles: Suppression of Copolymer-Mediated Complement Activation by Elevated Serum Levels of Hdl, Ldl, and Apolipoproteins Ai and B-100 J. Controlled Release 2013, 170, 167-174 10.1016/j.jconrel.2013.05.030
13. Devine, D. V.; Wong, K.; Serrano, K.; Chonn, A.; Cullis, P. R. Liposome-Complement Interactions in Rat Serum: Implications for Liposome Survival Studies Biochim. Biophys. Acta, Biomembr. 1994, 1191, 43-51 10.1016/0005-2736(94)90231-3
14. Borchard, G.; Kreuter, J. The Role of Serum Complement on the Organ Distribution of Intravenously Administered Poly (Methyl Methacrylate) Nanoparticles: Effects of Pre-Coating with Plasma and with Serum Complement Pharm. Res. 1996, 13, 1055-1058 10.1023/A:1016010808522
15. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E. Interaction of Colloidal Gold Nanoparticles with Human Blood: Effects on Particle Size and Analysis of Plasma Protein Binding Profiles Nanomedicine 2008, 5, 106-117 10.1016/j.nano.2008.08.001
16. Szebeni, J. Complement Activation-Related Pseudoallergy: A New Class of Drug-Induced Acute Immune Toxicity Toxicology 2005, 216, 106-121 10.1016/j.tox.2005.07.023
17. Pedersen, M. B.; Zhou, X.; Larsen, E. K.; Sorensen, U. S.; Kjems, J.; Nygaard, J. V.; Nyengaard, J. R.; Meyer, R. L.; Boesen, T.; Vorup-Jensen, T. Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation J. Immunol. 2010, 184, 1931-1945 10.4049/jimmunol.0902214
18. Peracchia, M. T.; Vauthier, C.; Passirani, C.; Couvreur, P.; Labarre, D. Complement Consumption by Poly(Ethylene Glycol) in Different Conformations Chemically Coupled to Poly(Isobutyl 2-Cyanoacrylate) Nanoparticles Life Sci. 1997, 61, 749-761 10.1016/S0024-3205(97)00539-0
19. Pham, C. T.; Mitchell, L. M.; Huang, J. L.; Lubniewski, C. M.; Schall, O. F.; Killgore, J. K.; Pan, D.; Wickline, S. A.; Lanza, G. M.; Hourcade, D. E. Variable Antibody-Dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces J. Biol. Chem. 2011, 286, 123-130 10.1074/jbc.M110.180760
20. Al-Hanbali, O.; Rutt, K. J.; Sarker, D. K.; Hunter, A. C.; Moghimi, S. M. Concentration Dependent Structural Ordering of Poloxamine 908 on Polystyrene Nanoparticles and Their Modulatory Role on Complement Consumption J. Nanosci. Nanotechnol. 2006, 6, 3126-3133 10.1166/jnn.2006.406
21. Moghimi, S. M.; Hamad, I.; Andresen, T. L.; Jorgensen, K.; Szebeni, J. Methylation of the Phosphate Oxygen Moiety of Phospholipid-Methoxy(Polyethylene Glycol) Conjugate Prevents Pegylated Liposome-Mediated Complement Activation and Anaphylatoxin Production FASEB J. 2006, 20, 2591-2593 10.1096/fj.06-6186fje
22. Salvador-Morales, C.; Zhang, L.; Langer, R.; Farokhzad, O. C. Immunocompatibility Properties of Lipid-Polymer Hybrid Nanoparticles with Heterogeneous Surface Functional Groups Biomaterials 2009, 30, 2231-2240 10.1016/j.biomaterials.2009.01.005
23. Moore, A.; Weissleder, R.; Bogdanov, A., Jr. Uptake of Dextran-Coated Monocrystalline Iron Oxides in Tumor Cells and Macrophages J. Magn. Reson. Imaging 1997, 7, 1140-1145 10.1002/jmri.1880070629
24. Figuerola, A.; Di Corato, R.; Manna, L.; Pellegrino, T. From Iron Oxide Nanoparticles Towards Advanced Iron-Based Inorganic Materials Designed for Biomedical Applications Pharmacol. Res. 2010, 62, 126-143 10.1016/j.phrs.2009.12.012
25. Park, J. H.; von Maltzahn, G.; Zhang, L.; Schwartz, M. P.; Ruoslahti, E.; Bhatia, S.; Sailor, M. J. Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging Adv. Mater. 2008, 20, 1630-1635 10.1002/adma.200800004
26. Wang, G.; Inturi, S.; Serkova, N. J.; Merkulov, S.; McCrae, K.; Russek, S. E.; Banda, N. K.; Simberg, D. High-Relaxivity Superparamagnetic Iron Oxide Nanoworms with Decreased Immune Recognition and Long-Circulating Properties ACS Nano 2014, 8, 12437-12449 10.1021/nn505126b
27. Karmali, P. P.; Chao, Y.; Park, J. H.; Sailor, M. J.; Ruoslahti, E.; Esener, S. C.; Simberg, D. Different Effect of Hydrogelation on Antifouling and Circulation Properties of Dextran-Iron Oxide Nanoparticles Mol. Pharmaceutics 2012, 9, 539-545 10.1021/mp200375x
28. Banda, N. K.; Mehta, G.; Chao, Y.; Wang, G.; Inturi, S.; Fossati-Jimack, L.; Botto, M.; Wu, L.; Moghimi, S.; Simberg, D. Mechanisms of Complement Activation by Dextran-Coated Superparamagnetic Iron Oxide (SPIO) Nanoworms in Mouse Versus Human Serum Part. Fibre Toxicol. 2014, 11, 64-73 10.1186/s12989-014-0064-2
29. Zamboni, W. C.; Maruca, L. J.; Strychor, S.; Zamboni, B. A.; Ramalingam, S.; Edwards, R. P.; Kim, J.; Bang, Y.; Lee, H.; Friedland, D. M. et al.et al. Bidirectional Pharmacodynamic Interaction between Pegylated Liposomal Ckd-602 (S-Ckd602) and Monocytes in Patients with Refractory Solid Tumors J. Liposome Res. 2011, 21, 158-165 10.3109/08982104.2010.496085
30. Wu, Y. J.; Muldoon, L. L.; Varallyay, C.; Markwardt, S.; Jones, R. E.; Neuwelt, E. A. In vivo Leukocyte Labeling with Intravenous Ferumoxides/Protamine Sulfate Complex and in vitro Characterization for Cellular Magnetic Resonance Imaging Am. J. Physiol. Cell Physiol. 2007, 293, C1698-1708 10.1152/ajpcell.00215.2007
31. Leroux, J. C.; Gravel, P.; Balant, L.; Volet, B.; Anner, B. M.; Allemann, E.; Doelker, E.; Gurny, R. Internalization of Poly(D,L-Lactic Acid) Nanoparticles by Isolated Human Leukocytes and Analysis of Plasma Proteins Adsorbed onto the Particles J. Biomed. Mater. Res. 1994, 28, 471-481 10.1002/jbm.820280410
32. Zambaux, M. F.; Faivre-Fiorina, B.; Bonneau, F.; Marchal, S.; Merlin, J. L.; Dellacherie, E.; Labrude, P.; Vigneron, C. Involvement of Neutrophilic Granulocytes in the Uptake of Biodegradable Non-Stealth and Stealth Nanoparticles in Guinea Pig Biomaterials 2000, 21, 975-980 10.1016/S0142-9612(99)00233-1
33. Bartneck, M.; Keul, H. A.; Singh, S.; Czaja, K.; Bornemann, J.; Bockstaller, M.; Moeller, M.; Zwadlo-Klarwasser, G.; Groll, J. Rapid Uptake of Gold Nanorods by Primary Human Blood Phagocytes and Immunomodulatory Effects of Surface Chemistry ACS Nano 2010, 4, 3073-3086 10.1021/nn100262h
34. Molday, R. S.; MacKenzie, D. Immunospecific Ferromagnetic Iron-Dextran Reagents for the Labeling and Magnetic Separation of Cells J. Immunol. Methods 1982, 52, 353-367 10.1016/0022-1759(82)90007-2
35. Gerges, N.; Rak, J.; Jabado, N. New Technologies for the Detection of Circulating Tumour Cells Br. Med. Bull. 2010, 94, 49-64 10.1093/bmb/ldq011
36. Estridge, B. H.; Reynolds, A. P. Normal Cell Morphology. In Basic Clinical Laboratory Techniques; Cengage Learning: Independence, KY, 2012; pp 291-293
37. Hiremath, P.; Bannigidad, P.; Geeta, S. Automated Identification and Classification of White Blood Cells (Leukocytes) in Digital Microscopic Images Int. J. Comput. Appl. 2010, 59-63
38. Putzu, L.; Caocci, G.; Di Ruberto, C. Leucocyte Classification for Leukaemia Detection Using Image Processing Techniques Artif. Intell. Med. 2014, 62, 179-191 10.1016/j.artmed.2014.09.002
39. Aslakson, C. J.; Miller, F. R. Selective Events in the Metastatic Process Defined by Analysis of the Sequential Dissemination of Subpopulations of a Mouse Mammary Tumor Cancer Res. 1992, 52, 1399-1405
40. Becker, H. M.; Chen, M.; Hay, J. B.; Cybulsky, M. I. Tracking of Leukocyte Recruitment into Tissues of Mice by in situ Labeling of Blood Cells with the Fluorescent Dye Cfda Se J. Immunol. Methods 2004, 286, 69-78 10.1016/j.jim.2003.11.016
41. Asquith, B.; Debacq, C.; Florins, A.; Gillet, N.; Sanchez-Alcaraz, T.; Mosley, A.; Willems, L. Quantifying Lymphocyte Kinetics in vivo Using Carboxyfluorescein Diacetate Succinimidyl Ester (Cfse) Proc. R. Soc. London, Ser. B 2006, 273, 1165-1171 10.1098/rspb.2005.3432
42. Kemper, C.; Atkinson, J. P.; Hourcade, D. E. Properdin: Emerging Roles of a Pattern-Recognition Molecule Annu. Rev. Immunol. 2010, 28, 131-155 10.1146/annurev-immunol-030409-101250
43. Gupta-Bansal, R.; Parent, J. B.; Brunden, K. R. Inhibition of Complement Alternative Pathway Function with Anti-Properdin Monoclonal Antibodies Mol. Immunol. 2000, 37, 191-201 10.1016/S0161-5890(00)00047-X
44. Park, J. H.; von Maltzahn, G.; Zhang, L.; Derfus, A. M.; Simberg, D.; Harris, T. J.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Systematic Surface Engineering of Magnetic Nanoworms for in vivo Tumor Targeting Small 2009, 5, 694-700 10.1002/smll.200801789
45. Wang, G.; Inturi, S.; Serkova, N. J.; Merkulov, S.; McCrae, K.; Russek, S. E.; Banda, N. K.; Simberg, D. High-Relaxivity Superparamagnetic Iron Oxide Nanoworms with Minimal Immune Recognition and Long-Circulating Properties ACS Nano 2014, 7, 4289-4298 10.1021/nn505126b
46. Dos Santos, N.; Allen, C.; Doppen, A. M.; Anantha, M.; Cox, K. A.; Gallagher, R. C.; Karlsson, G.; Edwards, K.; Kenner, G.; Samuels, L. et al.et al. Influence of Poly(Ethylene Glycol) Grafting Density and Polymer Length on Liposomes: Relating Plasma Circulation Lifetimes to Protein Binding Biochim. Biophys. Acta, Biomembr. 2007, 1768, 1367-1377 10.1016/j.bbamem.2006.12.013
47. Sengelov, H. Complement Receptors in Neutrophils Crit. Rev. Immunol. 1995, 15, 107-131 10.1615/CritRevImmunol.v15.i2.10
48. Heyman, B.; Wiersma, E. J.; Kinoshita, T. In vivo Inhibition of the Antibody Response by a Complement Receptor-Specific Monoclonal Antibody J. Exp. Med. 1990, 172, 665-668 10.1084/jem.172.2.665
49. Levy, E.; Ambrus, J.; Kahl, L.; Molina, H.; Tung, K.; Holers, V. M. T Lymphocyte Expression of Complement Receptor 2 (Cr2/Cd21): A Role in Adhesive Cell-Cell Interactions and Dysregulation in a Patient with Systemic Lupus Erythematosus (Sle) Clin. Exp. Immunol. 1992, 90, 235-244 10.1111/j.1365-2249.1992.tb07935.x
50. Verschoor, A.; Neuenhahn, M.; Navarini, A. A.; Graef, P.; Plaumann, A.; Seidlmeier, A.; Nieswandt, B.; Massberg, S.; Zinkernagel, R. M.; Hengartner, H. et al.et al. A Platelet-Mediated System for Shuttling Blood-Borne Bacteria to Cd8alpha+ Dendritic Cells Depends on Glycoprotein Gpib and Complement C3 Nat. Immunol. 2011, 12, 1194-1201 10.1038/ni.2140
51. Fitzgerald, J. R.; Foster, T. J.; Cox, D. The Interaction of Bacterial Pathogens with Platelets Nat. Rev. Microbiol. 2006, 4, 445-457 10.1038/nrmicro1425
52. Del Conde, I.; Cruz, M. A.; Zhang, H.; Lopez, J. A.; Afshar-Kharghan, V. Platelet Activation Leads to Activation and Propagation of the Complement System J. Exp. Med. 2005, 201, 871-879 10.1084/jem.20041497
53. Wiedmer, T.; Sims, P. J. Effect of Complement Proteins C5b-9 on Blood Platelets. Evidence for Reversible Depolarization of Membrane Potential J. Biol. Chem. 1985, 260, 8014-8019
54. Polley, M. J.; Nachman, R. L. Human Platelet Activation by C3a and C3a Des-Arg J. Exp. Med. 1983, 158, 603-615 10.1084/jem.158.2.603
55. Li, N.; Hu, H.; Lindqvist, M.; Wikstrom-Jonsson, E.; Goodall, A. H.; Hjemdahl, P. Platelet-Leukocyte Cross Talk in Whole Blood Arterioscler., Thromb., Vasc. Biol. 2000, 20, 2702-2708 10.1161/01.ATV.20.12.2702
56. Rinder, C. S.; Rinder, H. M.; Smith, B. R.; Fitch, J. C.; Smith, M. J.; Tracey, J. B.; Matis, L. A.; Squinto, S. P.; Rollins, S. A. Blockade of C5a and C5b-9 Generation Inhibits Leukocyte and Platelet Activation During Extracorporeal Circulation J. Clin. Invest. 1995, 96, 1564-1572 10.1172/JCI118195
57. Volk, L. D.; Flister, M. J.; Bivens, C. M.; Stutzman, A.; Desai, N.; Trieu, V.; Ran, S. Nab-Paclitaxel Efficacy in the Orthotopic Model of Human Breast Cancer Is Significantly Enhanced by Concurrent Anti-Vascular Endothelial Growth Factor a Therapy Neoplasia 2008, 10, 613-623 10.1593/neo.08302
58. Williams, T. J.; Jose, P. J. Mediation of Increased Vascular Permeability after Complement Activation. Histamine-Independent Action of Rabbit C5a J. Exp. Med. 1981, 153, 136-153 10.1084/jem.153.1.136
59. Rutkowski, M. J.; Sughrue, M. E.; Kane, A. J.; Mills, S. A.; Parsa, A. T. Cancer and the Complement Cascade Mol. Cancer Res. 2010, 8, 1453-1465 10.1158/1541-7786.MCR-10-0225
60. Moghimi, S. M. Cancer Nanomedicine and the Complement System Activation Paradigm: Anaphylaxis and Tumour Growth J. Controlled Release 2014, 190, 556-562 10.1016/j.jconrel.2014.03.051
61. Bambace, N. M.; Holmes, C. E. The Platelet Contribution to Cancer Progression J. Thromb. Haemostasis 2011, 9, 237-249 10.1111/j.1538-7836.2010.04131.x
62. Davis, B. P.; Rothenberg, M. E. Eosinophils and Cancer Cancer Immunol. Res. 2014, 2, 1-8 10.1158/2326-6066.CIR-13-0196
63. Cools-Lartigue, J.; Spicer, J.; McDonald, B.; Gowing, S.; Chow, S.; Giannias, B.; Bourdeau, F.; Kubes, P.; Ferri, L. Neutrophil Extracellular Traps Sequester Circulating Tumor Cells and Promote Metastasis J. Clin. Invest. 2013, 123, 3446-3458 10.1172/JCI67484
64. Spicer, J. D.; McDonald, B.; Cools-Lartigue, J. J.; Chow, S. C.; Giannias, B.; Kubes, P.; Ferri, L. E. Neutrophils Promote Liver Metastasis Via Mac-1-Mediated Interactions with Circulating Tumor Cells Cancer Res. 2012, 72, 3919-3927 10.1158/0008-5472.CAN-11-2393
65. Wirthmueller, U.; Dewald, B.; Thelen, M.; Schafer, M. K.; Stover, C.; Whaley, K.; North, J.; Eggleton, P.; Reid, K. B.; Schwaeble, W. J. Properdin, a Positive Regulator of Complement Activation, Is Released from Secondary Granules of Stimulated Peripheral Blood Neutrophils J. Immunol. 1997, 158, 4444-4451
66. Loveland, B. E.; Cebon, J. Cancer Exploiting Complement: A Clue or an Exception? Nat. Immunol. 2008, 9, 1205-1206 10.1038/ni1108-1205
67. Moghimi, S. M.; Farhangrazi, Z. S. Just So Stories: The Random Acts of Anti-Cancer Nanomedicine Performance Nanomedicine 2014, 10, 1661-1666 10.1016/j.nano.2014.04.011